{"Possible Vaccine Adverse Events":"1p36 deletion syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"2-Hydroxyglutaric aciduria","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"5'nucleotidase increased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Acoustic neuritis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Acquired C1 inhibitor deficiency","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Acquired epidermolysis bullosa","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Acquired epileptic aphasia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Acute cutaneous lupus erythematosus","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Acute disseminated encephalomyelitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Acute encephalitis with refractory, repetitive partial seizures","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Acute febrile neutrophilic dermatosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Acute flaccid myelitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Acute haemorrhagic leukoencephalitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Acute haemorrhagic oedema of infancy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Acute kidney injury","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Acute macular outer retinopathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Acute motor axonal neuropathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Acute motor-sensory axonal neuropathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Acute myocardial infarction","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Acute respiratory distress syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Acute respiratory failure","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Addison's disease","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Administration site thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Administration site vasculitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Adrenal thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Adverse event following immunisation","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Ageusia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Agranulocytosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Air embolism","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Alanine aminotransferase abnormal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Alanine aminotransferase increased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Alcoholic seizure","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Allergic bronchopulmonary mycosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Allergic oedema","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Alloimmune hepatitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Alopecia areata","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Alpers disease","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Alveolar proteinosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Ammonia abnormal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Ammonia increased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Amniotic cavity infection","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Amygdalohippocampectomy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Amyloid arthropathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Amyloidosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Amyloidosis senile","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anaphylactic reaction","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anaphylactic shock","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anaphylactic transfusion reaction","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anaphylactoid reaction","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anaphylactoid shock","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anaphylactoid syndrome of pregnancy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Angioedema","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Angiopathic neuropathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Ankylosing spondylitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anosmia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Antiacetylcholine receptor antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anti-actin antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anti-aquaporin-4 antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anti-basal ganglia antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anti-cyclic citrullinated peptide antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anti-epithelial antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anti-erythrocyte antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anti-exosome complex antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anti-GAD antibody negative","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anti-GAD antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anti-ganglioside antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Antigliadin antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anti-glomerular basement membrane antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anti-glomerular basement membrane disease","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anti-glycyl-tRNA synthetase antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anti-HLA antibody test positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anti-IA2 antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anti-insulin antibody increased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anti-insulin antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anti-insulin receptor antibody increased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anti-insulin receptor antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anti-interferon antibody negative","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anti-interferon antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anti-islet cell antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Antimitochondrial antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anti-muscle specific kinase antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anti-myelin-associated glycoprotein antibodies positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anti-myelin-associated glycoprotein associated polyneuropathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Antimyocardial antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anti-neuronal antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Antineutrophil cytoplasmic antibody increased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Antineutrophil cytoplasmic antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anti-neutrophil cytoplasmic antibody positive vasculitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anti-NMDA antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Antinuclear antibody increased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Antinuclear antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Antiphospholipid antibodies positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Antiphospholipid syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anti-platelet antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anti-prothrombin antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Antiribosomal P antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anti-RNA polymerase III antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anti-saccharomyces cerevisiae antibody test positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anti-sperm antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anti-SRP antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Antisynthetase syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anti-thyroid antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anti-transglutaminase antibody increased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anti-VGCC antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anti-VGKC antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anti-vimentin antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Antiviral prophylaxis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Antiviral treatment","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Anti-zinc transporter 8 antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Aortic embolus","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Aortic thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Aortitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Aplasia pure red cell","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Aplastic anaemia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Application site thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Application site vasculitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Arrhythmia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Arterial bypass occlusion","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Arterial bypass thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Arterial thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Arteriovenous fistula thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Arteriovenous graft site stenosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Arteriovenous graft thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Arteritis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Arteritis coronary","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Arthralgia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Arthritis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Arthritis enteropathic","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Ascites","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Aseptic cavernous sinus thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Aspartate aminotransferase abnormal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Aspartate aminotransferase increased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Aspartate-glutamate-transporter deficiency","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"AST to platelet ratio index increased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"AST/ALT ratio abnormal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Asthma","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Asymptomatic COVID-19","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Ataxia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Atheroembolism","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Atonic seizures","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Atrial thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Atrophic thyroiditis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Atypical benign partial epilepsy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Atypical pneumonia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Aura","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Autoantibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Autoimmune anaemia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Autoimmune aplastic anaemia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Autoimmune arthritis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Autoimmune blistering disease","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Autoimmune cholangitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Autoimmune colitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Autoimmune demyelinating disease","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Autoimmune dermatitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Autoimmune disorder","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Autoimmune encephalopathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Autoimmune endocrine disorder","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Autoimmune enteropathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Autoimmune eye disorder","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Autoimmune haemolytic anaemia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Autoimmune heparin-induced thrombocytopenia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Autoimmune hepatitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Autoimmune hyperlipidaemia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Autoimmune hypothyroidism","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Autoimmune inner ear disease","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Autoimmune lung disease","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Autoimmune lymphoproliferative syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Autoimmune myocarditis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Autoimmune myositis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Autoimmune nephritis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Autoimmune neuropathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Autoimmune neutropenia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Autoimmune pancreatitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Autoimmune pancytopenia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Autoimmune pericarditis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Autoimmune retinopathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Autoimmune thyroid disorder","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Autoimmune thyroiditis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Autoimmune uveitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Autoinflammation with infantile enterocolitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Autoinflammatory disease","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Automatism epileptic","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Autonomic nervous system imbalance","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Autonomic seizure","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Axial spondyloarthritis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Axillary vein thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Axonal and demyelinating polyneuropathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Axonal neuropathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Bacterascites","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Baltic myoclonic epilepsy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Band sensation","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Basedow's disease","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Basilar artery thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Basophilopenia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"B-cell aplasia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Behcet's syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Benign ethnic neutropenia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Benign familial neonatal convulsions","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Benign familial pemphigus","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Benign rolandic epilepsy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Beta-2 glycoprotein antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Bickerstaff's encephalitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Bile output abnormal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Bile output decreased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Biliary ascites","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Bilirubin conjugated abnormal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Bilirubin conjugated increased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Bilirubin urine present","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Biopsy liver abnormal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Biotinidase deficiency","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Birdshot chorioretinopathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Blood alkaline phosphatase abnormal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Blood alkaline phosphatase increased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Blood bilirubin abnormal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Blood bilirubin increased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Blood bilirubin unconjugated increased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Blood cholinesterase abnormal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Blood cholinesterase decreased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Blood pressure decreased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Blood pressure diastolic decreased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Blood pressure systolic decreased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Blue toe syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Brachiocephalic vein thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Brain stem embolism","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Brain stem thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Bromosulphthalein test abnormal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Bronchial oedema","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Bronchitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Bronchitis mycoplasmal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Bronchitis viral","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Bronchopulmonary aspergillosis allergic","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Bronchospasm","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Budd-Chiari syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Bulbar palsy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Butterfly rash","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"C1q nephropathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Caesarean section","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Calcium embolism","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Capillaritis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Caplan's syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cardiac amyloidosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cardiac arrest","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cardiac failure","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cardiac failure acute","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cardiac sarcoidosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cardiac ventricular thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cardiogenic shock","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cardiolipin antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cardiopulmonary failure","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cardio-respiratory arrest","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cardio-respiratory distress","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cardiovascular insufficiency","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Carotid arterial embolus","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Carotid artery thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cataplexy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Catheter site thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Catheter site vasculitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cavernous sinus thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"CDKL5 deficiency disorder","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"CEC syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cement embolism","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Central nervous system lupus","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Central nervous system vasculitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cerebellar artery thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cerebellar embolism","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cerebral amyloid angiopathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cerebral arteritis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cerebral artery embolism","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cerebral artery thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cerebral gas embolism","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cerebral microembolism","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cerebral septic infarct","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cerebral thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cerebral venous sinus thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cerebral venous thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cerebrospinal thrombotic tamponade","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cerebrovascular accident","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Change in seizure presentation","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Chest discomfort","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Child-Pugh-Turcotte score abnormal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Child-Pugh-Turcotte score increased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Chillblains","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Choking","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Choking sensation","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cholangitis sclerosing","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Chronic autoimmune glomerulonephritis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Chronic cutaneous lupus erythematosus","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Chronic fatigue syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Chronic gastritis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Chronic inflammatory demyelinating polyradiculoneuropathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Chronic recurrent multifocal osteomyelitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Chronic respiratory failure","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Chronic spontaneous urticaria","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Circulatory collapse","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Circumoral oedema","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Circumoral swelling","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Clinically isolated syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Clonic convulsion","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Coeliac disease","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cogan's syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cold agglutinins positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cold type haemolytic anaemia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Colitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Colitis erosive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Colitis herpes","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Colitis microscopic","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Colitis ulcerative","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Collagen disorder","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Collagen-vascular disease","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Complement factor abnormal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Complement factor C1 decreased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Complement factor C2 decreased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Complement factor C3 decreased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Complement factor C4 decreased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Complement factor decreased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Computerised tomogram liver abnormal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Concentric sclerosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Congenital anomaly","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Congenital bilateral perisylvian syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Congenital herpes simplex infection","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Congenital myasthenic syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Congenital varicella infection","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Congestive hepatopathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Convulsion in childhood","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Convulsions local","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Convulsive threshold lowered","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Coombs positive haemolytic anaemia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Coronary artery disease","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Coronary artery embolism","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Coronary artery thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Coronary bypass thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Coronavirus infection","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Coronavirus test","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Coronavirus test negative","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Coronavirus test positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Corpus callosotomy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cough","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cough variant asthma","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"COVID-19","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"COVID-19 immunisation","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"COVID-19 pneumonia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"COVID-19 prophylaxis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"COVID-19 treatment","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cranial nerve disorder","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cranial nerve palsies multiple","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cranial nerve paralysis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"CREST syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Crohn's disease","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cryofibrinogenaemia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cryoglobulinaemia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"CSF oligoclonal band present","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"CSWS syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cutaneous amyloidosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cutaneous lupus erythematosus","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cutaneous sarcoidosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cutaneous vasculitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cyanosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cyclic neutropenia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cystitis interstitial","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cytokine release syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Cytokine storm","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"De novo purine synthesis inhibitors associated acute inflammatory syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Death neonatal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Deep vein thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Deep vein thrombosis postoperative","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Deficiency of bile secretion","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Deja vu","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Demyelinating polyneuropathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Demyelination","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Dermatitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Dermatitis bullous","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Dermatitis herpetiformis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Dermatomyositis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Device embolisation","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Device related thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Diabetes mellitus","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Diabetic ketoacidosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Diabetic mastopathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Dialysis amyloidosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Dialysis membrane reaction","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Diastolic hypotension","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Diffuse vasculitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Digital pitting scar","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Disseminated intravascular coagulation","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Disseminated intravascular coagulation in newborn","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Disseminated neonatal herpes simplex","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Disseminated varicella","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Disseminated varicella zoster vaccine virus infection","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Disseminated varicella zoster virus infection","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"DNA antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Double cortex syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Double stranded DNA antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Dreamy state","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Dressler's syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Drop attacks","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Drug withdrawal convulsions","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Dyspnoea","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Early infantile epileptic encephalopathy with burst-suppression","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Eclampsia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Eczema herpeticum","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Embolia cutis medicamentosa","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Embolic cerebellar infarction","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Embolic cerebral infarction","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Embolic pneumonia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Embolic stroke","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Embolism","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Embolism arterial","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Embolism venous","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Encephalitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Encephalitis allergic","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Encephalitis autoimmune","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Encephalitis brain stem","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Encephalitis haemorrhagic","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Encephalitis periaxialis diffusa","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Encephalitis post immunisation","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Encephalomyelitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Encephalopathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Endocrine disorder","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Endocrine ophthalmopathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Endotracheal intubation","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Enteritis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Enteritis leukopenic","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Enterobacter pneumonia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Enterocolitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Enteropathic spondylitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Eosinopenia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Eosinophilic fasciitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Eosinophilic granulomatosis with polyangiitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Eosinophilic oesophagitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Epidermolysis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Epilepsy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Epilepsy surgery","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Epilepsy with myoclonic-atonic seizures","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Epileptic aura","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Epileptic psychosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Erythema","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Erythema induratum","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Erythema multiforme","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Erythema nodosum","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Evans syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Exanthema subitum","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Expanded disability status scale score decreased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Expanded disability status scale score increased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Exposure to communicable disease","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Exposure to SARS-CoV-2","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Eye oedema","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Eye pruritus","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Eye swelling","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Eyelid oedema","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Face oedema","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Facial paralysis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Facial paresis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Faciobrachial dystonic seizure","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Fat embolism","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Febrile convulsion","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Febrile infection-related epilepsy syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Febrile neutropenia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Felty's syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Femoral artery embolism","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Fibrillary glomerulonephritis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Fibromyalgia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Flushing","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Foaming at mouth","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Focal cortical resection","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Focal dyscognitive seizures","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Foetal distress syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Foetal placental thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Foetor hepaticus","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Foreign body embolism","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Frontal lobe epilepsy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Fulminant type 1 diabetes mellitus","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Galactose elimination capacity test abnormal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Galactose elimination capacity test decreased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Gamma-glutamyltransferase abnormal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Gamma-glutamyltransferase increased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Gastritis herpes","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Gastrointestinal amyloidosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Gelastic seizure","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Generalised onset non-motor seizure","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Generalised tonic-clonic seizure","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Genital herpes","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Genital herpes simplex","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Genital herpes zoster","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Giant cell arteritis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Glomerulonephritis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Glomerulonephritis membranoproliferative","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Glomerulonephritis membranous","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Glomerulonephritis rapidly progressive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Glossopharyngeal nerve paralysis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Glucose transporter type 1 deficiency syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Glutamate dehydrogenase increased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Glycocholic acid increased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"GM2 gangliosidosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Goodpasture's syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Graft thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Granulocytopenia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Granulocytopenia neonatal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Granulomatosis with polyangiitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Granulomatous dermatitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Grey matter heterotopia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Guanase increased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Guillain-Barre syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Haemolytic anaemia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Haemophagocytic lymphohistiocytosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Haemorrhage","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Haemorrhagic ascites","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Haemorrhagic disorder","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Haemorrhagic pneumonia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Haemorrhagic varicella syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Haemorrhagic vasculitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hantavirus pulmonary infection","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hashimoto's encephalopathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hashitoxicosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hemimegalencephaly","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Henoch-Schonlein purpura","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Henoch-Schonlein purpura nephritis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hepaplastin abnormal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hepaplastin decreased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Heparin-induced thrombocytopenia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hepatic amyloidosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hepatic artery embolism","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hepatic artery flow decreased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hepatic artery thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hepatic enzyme abnormal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hepatic enzyme decreased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hepatic enzyme increased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hepatic fibrosis marker abnormal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hepatic fibrosis marker increased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hepatic function abnormal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hepatic hydrothorax","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hepatic hypertrophy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hepatic hypoperfusion","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hepatic lymphocytic infiltration","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hepatic mass","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hepatic pain","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hepatic sequestration","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hepatic vascular resistance increased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hepatic vascular thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hepatic vein embolism","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hepatic vein thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hepatic venous pressure gradient abnormal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hepatic venous pressure gradient increased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hepatitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hepatobiliary scan abnormal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hepatomegaly","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hepatosplenomegaly","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hereditary angioedema with C1 esterase inhibitor deficiency","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Herpes dermatitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Herpes gestationis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Herpes oesophagitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Herpes ophthalmic","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Herpes pharyngitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Herpes sepsis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Herpes simplex","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Herpes simplex cervicitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Herpes simplex colitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Herpes simplex encephalitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Herpes simplex gastritis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Herpes simplex hepatitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Herpes simplex meningitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Herpes simplex meningoencephalitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Herpes simplex meningomyelitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Herpes simplex necrotising retinopathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Herpes simplex oesophagitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Herpes simplex otitis externa","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Herpes simplex pharyngitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Herpes simplex pneumonia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Herpes simplex reactivation","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Herpes simplex sepsis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Herpes simplex viraemia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Herpes simplex virus conjunctivitis neonatal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Herpes simplex visceral","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Herpes virus infection","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Herpes zoster","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Herpes zoster cutaneous disseminated","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Herpes zoster infection neurological","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Herpes zoster meningitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Herpes zoster meningoencephalitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Herpes zoster meningomyelitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Herpes zoster meningoradiculitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Herpes zoster necrotising retinopathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Herpes zoster oticus","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Herpes zoster pharyngitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Herpes zoster reactivation","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Herpetic radiculopathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Histone antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hoigne's syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Human herpesvirus 6 encephalitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Human herpesvirus 6 infection","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Human herpesvirus 6 infection reactivation","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Human herpesvirus 7 infection","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Human herpesvirus 8 infection","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hyperammonaemia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hyperbilirubinaemia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hypercholia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hypergammaglobulinaemia benign monoclonal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hyperglycaemic seizure","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hypersensitivity","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hypersensitivity vasculitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hyperthyroidism","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hypertransaminasaemia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hyperventilation","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hypoalbuminaemia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hypocalcaemic seizure","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hypogammaglobulinaemia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hypoglossal nerve paralysis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hypoglossal nerve paresis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hypoglycaemic seizure","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hyponatraemic seizure","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hypotension","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hypotensive crisis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hypothenar hammer syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hypothyroidism","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Hypoxia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Idiopathic CD4 lymphocytopenia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Idiopathic generalised epilepsy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Idiopathic interstitial pneumonia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Idiopathic neutropenia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Idiopathic pulmonary fibrosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"IgA nephropathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"IgM nephropathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"IIIrd nerve paralysis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"IIIrd nerve paresis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Iliac artery embolism","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Immune thrombocytopenia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Immune-mediated adverse reaction","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Immune-mediated cholangitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Immune-mediated cholestasis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Immune-mediated cytopenia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Immune-mediated encephalitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Immune-mediated encephalopathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Immune-mediated endocrinopathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Immune-mediated enterocolitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Immune-mediated gastritis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Immune-mediated hepatic disorder","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Immune-mediated hepatitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Immune-mediated hyperthyroidism","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Immune-mediated hypothyroidism","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Immune-mediated myocarditis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Immune-mediated myositis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Immune-mediated nephritis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Immune-mediated neuropathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Immune-mediated pancreatitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Immune-mediated pneumonitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Immune-mediated renal disorder","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Immune-mediated thyroiditis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Immune-mediated uveitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Immunoglobulin G4 related disease","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Immunoglobulins abnormal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Implant site thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Inclusion body myositis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Infantile genetic agranulocytosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Infantile spasms","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Infected vasculitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Infective thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Inflammation","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Inflammatory bowel disease","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Infusion site thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Infusion site vasculitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Injection site thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Injection site urticaria","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Injection site vasculitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Instillation site thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Insulin autoimmune syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Interstitial granulomatous dermatitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Interstitial lung disease","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Intracardiac mass","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Intracardiac thrombus","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Intracranial pressure increased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Intrapericardial thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Intrinsic factor antibody abnormal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Intrinsic factor antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"IPEX syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Irregular breathing","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"IRVAN syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"IVth nerve paralysis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"IVth nerve paresis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"JC polyomavirus test positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"JC virus CSF test positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Jeavons syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Jugular vein embolism","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Jugular vein thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Juvenile idiopathic arthritis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Juvenile myoclonic epilepsy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Juvenile polymyositis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Juvenile psoriatic arthritis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Juvenile spondyloarthritis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Kaposi sarcoma inflammatory cytokine syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Kawasaki's disease","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Kayser-Fleischer ring","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Keratoderma blenorrhagica","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Ketosis-prone diabetes mellitus","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Kounis syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Lafora's myoclonic epilepsy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Lambl's excrescences","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Laryngeal dyspnoea","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Laryngeal oedema","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Laryngeal rheumatoid arthritis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Laryngospasm","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Laryngotracheal oedema","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Latent autoimmune diabetes in adults","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"LE cells present","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Lemierre syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Lennox-Gastaut syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Leucine aminopeptidase increased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Leukoencephalomyelitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Leukoencephalopathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Leukopenia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Leukopenia neonatal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Lewis-Sumner syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Lhermitte's sign","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Lichen planopilaris","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Lichen planus","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Lichen sclerosus","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Limbic encephalitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Linear IgA disease","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Lip oedema","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Lip swelling","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Liver function test abnormal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Liver function test decreased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Liver function test increased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Liver induration","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Liver injury","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Liver iron concentration abnormal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Liver iron concentration increased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Liver opacity","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Liver palpable","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Liver sarcoidosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Liver scan abnormal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Liver tenderness","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Low birth weight baby","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Lower respiratory tract herpes infection","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Lower respiratory tract infection","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Lower respiratory tract infection viral","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Lung abscess","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Lupoid hepatic cirrhosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Lupus cystitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Lupus encephalitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Lupus endocarditis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Lupus enteritis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Lupus hepatitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Lupus myocarditis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Lupus myositis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Lupus nephritis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Lupus pancreatitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Lupus pleurisy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Lupus pneumonitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Lupus vasculitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Lupus-like syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Lymphocytic hypophysitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Lymphocytopenia neonatal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Lymphopenia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"MAGIC syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Magnetic resonance imaging liver abnormal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Magnetic resonance proton density fat fraction measurement","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Mahler sign","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Manufacturing laboratory analytical testing issue","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Manufacturing materials issue","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Manufacturing production issue","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Marburg's variant multiple sclerosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Marchiafava-Bignami disease","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Marine Lenhart syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Mastocytic enterocolitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Maternal exposure during pregnancy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Medical device site thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Medical device site vasculitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"MELAS syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Meningitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Meningitis aseptic","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Meningitis herpes","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Meningoencephalitis herpes simplex neonatal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Meningoencephalitis herpetic","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Meningomyelitis herpes","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"MERS-CoV test","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"MERS-CoV test negative","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"MERS-CoV test positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Mesangioproliferative glomerulonephritis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Mesenteric artery embolism","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Mesenteric artery thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Mesenteric vein thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Metapneumovirus infection","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Metastatic cutaneous Crohn's disease","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Metastatic pulmonary embolism","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Microangiopathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Microembolism","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Microscopic polyangiitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Middle East respiratory syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Migraine-triggered seizure","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Miliary pneumonia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Miller Fisher syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Mitochondrial aspartate aminotransferase increased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Mixed connective tissue disease","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Model for end stage liver disease score abnormal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Model for end stage liver disease score increased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Molar ratio of total branched-chain amino acid to tyrosine","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Molybdenum cofactor deficiency","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Monocytopenia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Mononeuritis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Mononeuropathy multiplex","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Morphoea","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Morvan syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Mouth swelling","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Moyamoya disease","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Multifocal motor neuropathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Multiple organ dysfunction syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Multiple sclerosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Multiple sclerosis relapse","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Multiple sclerosis relapse prophylaxis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Multiple subpial transection","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Multisystem inflammatory syndrome in children","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Muscular sarcoidosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Myasthenia gravis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Myasthenia gravis crisis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Myasthenia gravis neonatal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Myasthenic syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Myelitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Myelitis transverse","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Myocardial infarction","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Myocarditis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Myocarditis post infection","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Myoclonic epilepsy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Myoclonic epilepsy and ragged-red fibres","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Myokymia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Myositis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Narcolepsy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Nasal herpes","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Nasal obstruction","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Necrotising herpetic retinopathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Neonatal Crohn's disease","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Neonatal epileptic seizure","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Neonatal lupus erythematosus","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Neonatal mucocutaneous herpes simplex","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Neonatal pneumonia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Neonatal seizure","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Nephritis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Nephrogenic systemic fibrosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Neuralgic amyotrophy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Neuritis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Neuritis cranial","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Neuromyelitis optica pseudo relapse","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Neuromyelitis optica spectrum disorder","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Neuromyotonia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Neuronal neuropathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Neuropathy peripheral","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Neuropathy, ataxia, retinitis pigmentosa syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Neuropsychiatric lupus","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Neurosarcoidosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Neutropenia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Neutropenia neonatal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Neutropenic colitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Neutropenic infection","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Neutropenic sepsis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Nodular rash","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Nodular vasculitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Noninfectious myelitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Noninfective encephalitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Noninfective encephalomyelitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Noninfective oophoritis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Obstetrical pulmonary embolism","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Occupational exposure to communicable disease","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Occupational exposure to SARS-CoV-2","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Ocular hyperaemia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Ocular myasthenia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Ocular pemphigoid","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Ocular sarcoidosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Ocular vasculitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Oculofacial paralysis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Oedema","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Oedema blister","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Oedema due to hepatic disease","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Oedema mouth","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Oesophageal achalasia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Ophthalmic artery thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Ophthalmic herpes simplex","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Ophthalmic herpes zoster","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Ophthalmic vein thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Optic neuritis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Optic neuropathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Optic perineuritis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Oral herpes","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Oral lichen planus","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Oropharyngeal oedema","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Oropharyngeal spasm","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Oropharyngeal swelling","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Osmotic demyelination syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Ovarian vein thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Overlap syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Paget-Schroetter syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Palindromic rheumatism","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Palisaded neutrophilic granulomatous dermatitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Palmoplantar keratoderma","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Palpable purpura","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pancreatitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Panencephalitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Papillophlebitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Paracancerous pneumonia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Paradoxical embolism","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Parainfluenzae viral laryngotracheobronchitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Paraneoplastic dermatomyositis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Paraneoplastic pemphigus","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Paraneoplastic thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Paresis cranial nerve","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Parietal cell antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Paroxysmal nocturnal haemoglobinuria","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Partial seizures","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Partial seizures with secondary generalisation","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Patient isolation","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pelvic venous thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pemphigoid","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pemphigus","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Penile vein thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pericarditis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pericarditis lupus","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Perihepatic discomfort","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Periorbital oedema","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Periorbital swelling","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Peripheral artery thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Peripheral embolism","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Peripheral ischaemia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Peripheral vein thrombus extension","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Periportal oedema","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Peritoneal fluid protein abnormal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Peritoneal fluid protein decreased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Peritoneal fluid protein increased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Peritonitis lupus","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pernicious anaemia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Petit mal epilepsy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pharyngeal oedema","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pharyngeal swelling","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pityriasis lichenoides et varioliformis acuta","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Placenta praevia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pleuroparenchymal fibroelastosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pneumobilia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pneumonia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pneumonia adenoviral","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pneumonia cytomegaloviral","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pneumonia herpes viral","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pneumonia influenzal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pneumonia measles","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pneumonia mycoplasmal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pneumonia necrotising","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pneumonia parainfluenzae viral","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pneumonia respiratory syncytial viral","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pneumonia viral","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"POEMS syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Polyarteritis nodosa","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Polyarthritis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Polychondritis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Polyglandular autoimmune syndrome type I","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Polyglandular autoimmune syndrome type II","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Polyglandular autoimmune syndrome type III","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Polyglandular disorder","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Polymicrogyria","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Polymyalgia rheumatica","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Polymyositis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Polyneuropathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Polyneuropathy idiopathic progressive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Portal pyaemia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Portal vein embolism","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Portal vein flow decreased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Portal vein pressure increased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Portal vein thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Portosplenomesenteric venous thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Post procedural hypotension","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Post procedural pneumonia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Post procedural pulmonary embolism","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Post stroke epilepsy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Post stroke seizure","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Post thrombotic retinopathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Post thrombotic syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Post viral fatigue syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Postictal headache","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Postictal paralysis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Postictal psychosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Postictal state","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Postoperative respiratory distress","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Postoperative respiratory failure","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Postoperative thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Postpartum thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Postpartum venous thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Postpericardiotomy syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Post-traumatic epilepsy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Postural orthostatic tachycardia syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Precerebral artery thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pre-eclampsia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Preictal state","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Premature labour","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Premature menopause","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Primary amyloidosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Primary biliary cholangitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Primary progressive multiple sclerosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Procedural shock","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Proctitis herpes","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Proctitis ulcerative","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Product availability issue","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Product distribution issue","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Product supply issue","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Progressive facial hemiatrophy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Progressive multifocal leukoencephalopathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Progressive multiple sclerosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Progressive relapsing multiple sclerosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Prosthetic cardiac valve thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pruritus","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pruritus allergic","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pseudovasculitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Psoriasis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Psoriatic arthropathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pulmonary amyloidosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pulmonary artery thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pulmonary embolism","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pulmonary fibrosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pulmonary haemorrhage","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pulmonary microemboli","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pulmonary oil microembolism","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pulmonary renal syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pulmonary sarcoidosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pulmonary sepsis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pulmonary thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pulmonary tumour thrombotic microangiopathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pulmonary vasculitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pulmonary veno-occlusive disease","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pulmonary venous thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pyoderma gangrenosum","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pyostomatitis vegetans","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Pyrexia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Quarantine","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Radiation leukopenia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Radiculitis brachial","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Radiologically isolated syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Rash","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Rash erythematous","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Rash pruritic","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Rasmussen encephalitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Raynaud's phenomenon","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Reactive capillary endothelial proliferation","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Relapsing multiple sclerosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Relapsing-remitting multiple sclerosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Renal amyloidosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Renal arteritis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Renal artery thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Renal embolism","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Renal failure","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Renal vascular thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Renal vasculitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Renal vein embolism","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Renal vein thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Respiratory arrest","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Respiratory disorder","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Respiratory distress","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Respiratory failure","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Respiratory paralysis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Respiratory syncytial virus bronchiolitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Respiratory syncytial virus bronchitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Retinal artery embolism","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Retinal artery occlusion","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Retinal artery thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Retinal vascular thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Retinal vasculitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Retinal vein occlusion","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Retinal vein thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Retinol binding protein decreased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Retinopathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Retrograde portal vein flow","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Retroperitoneal fibrosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Reversible airways obstruction","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Reynold's syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Rheumatic brain disease","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Rheumatic disorder","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Rheumatoid arthritis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Rheumatoid factor increased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Rheumatoid factor positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Rheumatoid factor quantitative increased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Rheumatoid lung","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Rheumatoid neutrophilic dermatosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Rheumatoid nodule","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Rheumatoid nodule removal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Rheumatoid scleritis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Rheumatoid vasculitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Saccadic eye movement","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"SAPHO syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Sarcoidosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"SARS-CoV-1 test","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"SARS-CoV-1 test negative","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"SARS-CoV-1 test positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"SARS-CoV-2 antibody test","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"SARS-CoV-2 antibody test negative","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"SARS-CoV-2 antibody test positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"SARS-CoV-2 carrier","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"SARS-CoV-2 sepsis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"SARS-CoV-2 test","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"SARS-CoV-2 test false negative","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"SARS-CoV-2 test false positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"SARS-CoV-2 test negative","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"SARS-CoV-2 test positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"SARS-CoV-2 viraemia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Satoyoshi syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Schizencephaly","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Scleritis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Sclerodactylia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Scleroderma","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Scleroderma associated digital ulcer","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Scleroderma renal crisis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Scleroderma-like reaction","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Secondary amyloidosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Secondary cerebellar degeneration","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Secondary progressive multiple sclerosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Segmented hyalinising vasculitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Seizure","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Seizure anoxic","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Seizure cluster","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Seizure like phenomena","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Seizure prophylaxis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Sensation of foreign body","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Septic embolus","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Septic pulmonary embolism","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Severe acute respiratory syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Severe myoclonic epilepsy of infancy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Shock","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Shock symptom","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Shrinking lung syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Shunt thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Silent thyroiditis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Simple partial seizures","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Sjogren's syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Skin swelling","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"SLE arthritis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Smooth muscle antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Sneezing","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Spinal artery embolism","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Spinal artery thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Splenic artery thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Splenic embolism","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Splenic thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Splenic vein thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Spondylitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Spondyloarthropathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Spontaneous heparin-induced thrombocytopenia syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Status epilepticus","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Stevens-Johnson syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Stiff leg syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Stiff person syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Stillbirth","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Still's disease","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Stoma site thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Stoma site vasculitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Stress cardiomyopathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Stridor","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Subacute cutaneous lupus erythematosus","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Subacute endocarditis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Subacute inflammatory demyelinating polyneuropathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Subclavian artery embolism","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Subclavian artery thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Subclavian vein thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Sudden unexplained death in epilepsy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Superior sagittal sinus thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Susac's syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Suspected COVID-19","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Swelling","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Swelling face","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Swelling of eyelid","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Swollen tongue","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Sympathetic ophthalmia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Systemic lupus erythematosus","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Systemic lupus erythematosus disease activity index abnormal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Systemic lupus erythematosus disease activity index decreased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Systemic lupus erythematosus disease activity index increased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Systemic lupus erythematosus rash","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Systemic scleroderma","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Systemic sclerosis pulmonary","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Tachycardia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Tachypnoea","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Takayasu's arteritis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Temporal lobe epilepsy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Terminal ileitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Testicular autoimmunity","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Throat tightness","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Thromboangiitis obliterans","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Thrombocytopenia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Thrombocytopenic purpura","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Thrombophlebitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Thrombophlebitis migrans","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Thrombophlebitis neonatal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Thrombophlebitis septic","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Thrombophlebitis superficial","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Thromboplastin antibody positive","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Thrombosis corpora cavernosa","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Thrombosis in device","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Thrombosis mesenteric vessel","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Thrombotic cerebral infarction","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Thrombotic microangiopathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Thrombotic stroke","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Thrombotic thrombocytopenic purpura","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Thyroid disorder","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Thyroid stimulating immunoglobulin increased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Thyroiditis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Tongue amyloidosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Tongue biting","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Tongue oedema","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Tonic clonic movements","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Tonic convulsion","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Tonic posturing","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Topectomy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Total bile acids increased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Toxic epidermal necrolysis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Toxic leukoencephalopathy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Toxic oil syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Tracheal obstruction","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Tracheal oedema","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Tracheobronchitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Tracheobronchitis mycoplasmal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Tracheobronchitis viral","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Transaminases abnormal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Transaminases increased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Transfusion-related alloimmune neutropenia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Transient epileptic amnesia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Transverse sinus thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Trigeminal nerve paresis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Trigeminal neuralgia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Trigeminal palsy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Truncus coeliacus thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Tuberous sclerosis complex","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Tubulointerstitial nephritis and uveitis syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Tumefactive multiple sclerosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Tumour embolism","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Tumour thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Type 1 diabetes mellitus","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Type I hypersensitivity","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Type III immune complex mediated reaction","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Uhthoff's phenomenon","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Ulcerative keratitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Ultrasound liver abnormal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Umbilical cord thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Uncinate fits","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Undifferentiated connective tissue disease","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Upper airway obstruction","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Urine bilirubin increased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Urobilinogen urine decreased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Urobilinogen urine increased","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Urticaria","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Urticaria papular","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Urticarial vasculitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Uterine rupture","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Uveitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Vaccination site thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Vaccination site vasculitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Vagus nerve paralysis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Varicella","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Varicella keratitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Varicella post vaccine","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Varicella zoster gastritis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Varicella zoster oesophagitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Varicella zoster pneumonia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Varicella zoster sepsis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Varicella zoster virus infection","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Vasa praevia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Vascular graft thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Vascular pseudoaneurysm thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Vascular purpura","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Vascular stent thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Vasculitic rash","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Vasculitic ulcer","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Vasculitis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Vasculitis gastrointestinal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Vasculitis necrotising","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Vena cava embolism","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Vena cava thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Venous intravasation","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Venous recanalisation","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Venous thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Venous thrombosis in pregnancy","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Venous thrombosis limb","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Venous thrombosis neonatal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Vertebral artery thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Vessel puncture site thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Visceral venous thrombosis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"VIth nerve paralysis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"VIth nerve paresis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Vitiligo","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Vocal cord paralysis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Vocal cord paresis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Vogt-Koyanagi-Harada disease","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Warm type haemolytic anaemia","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Wheezing","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"White nipple sign","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"XIth nerve paralysis","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"X-ray hepatobiliary abnormal","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Young's syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Zika virus associated Guillain Barre syndrome","Source Title":"5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021 Report","Source Author":"Worldwide Safety Pfizer","Source Date":"2021-04-30","Source Additional Information":"pages 30-38; Document was released as part of a Freedom of Information Act (FOIA) lawsuit against the United States Food and Drug Administration (FDA) filed by the Public Health and Medical Professionals for Transparency non-profit organization","Source URL":"https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf"}
{"Possible Vaccine Adverse Events":"Adenopathy","Source Title":"Neuritis and Multiple Neuritis Following Serum Therapy","Source Author":"George Wilson, M.D. and Samuel B. Hadden, M.D.","Source Date":"1932-01-09","Source Additional Information":"'JAMA'. 1932; 98(2), pages 123-125","Source URL":"https://jamanetwork.com/journals/jama/article-abstract/1153665"}
{"Possible Vaccine Adverse Events":"Anaphylaxis","Source Title":"Neuritis and Multiple Neuritis Following Serum Therapy","Source Author":"George Wilson, M.D. and Samuel B. Hadden, M.D.","Source Date":"1932-01-09","Source Additional Information":"'JAMA'. 1932; 98(2), pages 123-125","Source URL":"https://jamanetwork.com/journals/jama/article-abstract/1153665"}
{"Possible Vaccine Adverse Events":"Arthralgia","Source Title":"Neuritis and Multiple Neuritis Following Serum Therapy","Source Author":"George Wilson, M.D. and Samuel B. Hadden, M.D.","Source Date":"1932-01-09","Source Additional Information":"'JAMA'. 1932; 98(2), pages 123-125","Source URL":"https://jamanetwork.com/journals/jama/article-abstract/1153665"}
{"Possible Vaccine Adverse Events":"Cardiac collapse","Source Title":"Neuritis and Multiple Neuritis Following Serum Therapy","Source Author":"George Wilson, M.D. and Samuel B. Hadden, M.D.","Source Date":"1932-01-09","Source Additional Information":"'JAMA'. 1932; 98(2), pages 123-125","Source URL":"https://jamanetwork.com/journals/jama/article-abstract/1153665"}
{"Possible Vaccine Adverse Events":"Coma","Source Title":"Neuritis and Multiple Neuritis Following Serum Therapy","Source Author":"George Wilson, M.D. and Samuel B. Hadden, M.D.","Source Date":"1932-01-09","Source Additional Information":"'JAMA'. 1932; 98(2), pages 123-125","Source URL":"https://jamanetwork.com/journals/jama/article-abstract/1153665"}
{"Possible Vaccine Adverse Events":"Death","Source Title":"Neuritis and Multiple Neuritis Following Serum Therapy","Source Author":"George Wilson, M.D. and Samuel B. Hadden, M.D.","Source Date":"1932-01-09","Source Additional Information":"'JAMA'. 1932; 98(2), pages 123-125","Source URL":"https://jamanetwork.com/journals/jama/article-abstract/1153665"}
{"Possible Vaccine Adverse Events":"Encephalitis","Source Title":"Neuritis and Multiple Neuritis Following Serum Therapy","Source Author":"George Wilson, M.D. and Samuel B. Hadden, M.D.","Source Date":"1932-01-09","Source Additional Information":"'JAMA'. 1932; 98(2), pages 123-125","Source URL":"https://jamanetwork.com/journals/jama/article-abstract/1153665"}
{"Possible Vaccine Adverse Events":"Multiple neuritis","Source Title":"Neuritis and Multiple Neuritis Following Serum Therapy","Source Author":"George Wilson, M.D. and Samuel B. Hadden, M.D.","Source Date":"1932-01-09","Source Additional Information":"'JAMA'. 1932; 98(2), pages 123-125","Source URL":"https://jamanetwork.com/journals/jama/article-abstract/1153665"}
{"Possible Vaccine Adverse Events":"Myelitis","Source Title":"Neuritis and Multiple Neuritis Following Serum Therapy","Source Author":"George Wilson, M.D. and Samuel B. Hadden, M.D.","Source Date":"1932-01-09","Source Additional Information":"'JAMA'. 1932; 98(2), pages 123-125","Source URL":"https://jamanetwork.com/journals/jama/article-abstract/1153665"}
{"Possible Vaccine Adverse Events":"Paralysis of the serratus magnus and other muscles","Source Title":"Neuritis and Multiple Neuritis Following Serum Therapy","Source Author":"George Wilson, M.D. and Samuel B. Hadden, M.D.","Source Date":"1932-01-09","Source Additional Information":"'JAMA'. 1932; 98(2), pages 123-125","Source URL":"https://jamanetwork.com/journals/jama/article-abstract/1153665"}
{"Possible Vaccine Adverse Events":"Urticaria","Source Title":"Neuritis and Multiple Neuritis Following Serum Therapy","Source Author":"George Wilson, M.D. and Samuel B. Hadden, M.D.","Source Date":"1932-01-09","Source Additional Information":"'JAMA'. 1932; 98(2), pages 123-125","Source URL":"https://jamanetwork.com/journals/jama/article-abstract/1153665"}
{"Possible Vaccine Adverse Events":"Acute disseminated encephalomyelitis","Source Title":"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation","Source Author":"Steve Anderson, PhD, MPP","Source Date":"2020-10-22","Source Additional Information":"page 17; Document was Recovered with the Internet Archive: Wayback Machine","Source URL":"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download"}
{"Possible Vaccine Adverse Events":"Acute myocardial infarction","Source Title":"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation","Source Author":"Steve Anderson, PhD, MPP","Source Date":"2020-10-22","Source Additional Information":"page 17; Document was Recovered with the Internet Archive: Wayback Machine","Source URL":"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download"}
{"Possible Vaccine Adverse Events":"Anaphylaxis","Source Title":"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation","Source Author":"Steve Anderson, PhD, MPP","Source Date":"2020-10-22","Source Additional Information":"page 17; Document was Recovered with the Internet Archive: Wayback Machine","Source URL":"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download"}
{"Possible Vaccine Adverse Events":"Arthritis and arthralgia/joint pain","Source Title":"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation","Source Author":"Steve Anderson, PhD, MPP","Source Date":"2020-10-22","Source Additional Information":"page 17; Document was Recovered with the Internet Archive: Wayback Machine","Source URL":"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download"}
{"Possible Vaccine Adverse Events":"Autoimmune disease","Source Title":"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation","Source Author":"Steve Anderson, PhD, MPP","Source Date":"2020-10-22","Source Additional Information":"page 17; Document was Recovered with the Internet Archive: Wayback Machine","Source URL":"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download"}
{"Possible Vaccine Adverse Events":"Convulsions/seizures","Source Title":"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation","Source Author":"Steve Anderson, PhD, MPP","Source Date":"2020-10-22","Source Additional Information":"page 17; Document was Recovered with the Internet Archive: Wayback Machine","Source URL":"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download"}
{"Possible Vaccine Adverse Events":"Deaths","Source Title":"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation","Source Author":"Steve Anderson, PhD, MPP","Source Date":"2020-10-22","Source Additional Information":"page 17; Document was Recovered with the Internet Archive: Wayback Machine","Source URL":"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download"}
{"Possible Vaccine Adverse Events":"Disseminated intravascular coagulation","Source Title":"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation","Source Author":"Steve Anderson, PhD, MPP","Source Date":"2020-10-22","Source Additional Information":"page 17; Document was Recovered with the Internet Archive: Wayback Machine","Source URL":"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download"}
{"Possible Vaccine Adverse Events":"Encephalitis","Source Title":"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation","Source Author":"Steve Anderson, PhD, MPP","Source Date":"2020-10-22","Source Additional Information":"page 17; Document was Recovered with the Internet Archive: Wayback Machine","Source URL":"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download"}
{"Possible Vaccine Adverse Events":"Encephalitis/myelitis/encephalomyelitis/meningoencephalitis/meningitis/encepholapathy","Source Title":"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation","Source Author":"Steve Anderson, PhD, MPP","Source Date":"2020-10-22","Source Additional Information":"page 17; Document was Recovered with the Internet Archive: Wayback Machine","Source URL":"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download"}
{"Possible Vaccine Adverse Events":"Encephalomyelitis","Source Title":"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation","Source Author":"Steve Anderson, PhD, MPP","Source Date":"2020-10-22","Source Additional Information":"page 17; Document was Recovered with the Internet Archive: Wayback Machine","Source URL":"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download"}
{"Possible Vaccine Adverse Events":"Encepholapathy","Source Title":"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation","Source Author":"Steve Anderson, PhD, MPP","Source Date":"2020-10-22","Source Additional Information":"page 17; Document was Recovered with the Internet Archive: Wayback Machine","Source URL":"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download"}
{"Possible Vaccine Adverse Events":"Guillain-Barr\u001a\u001a syndrome","Source Title":"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation","Source Author":"Steve Anderson, PhD, MPP","Source Date":"2020-10-22","Source Additional Information":"page 17; Document was Recovered with the Internet Archive: Wayback Machine","Source URL":"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download"}
{"Possible Vaccine Adverse Events":"Kawasaki disease","Source Title":"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation","Source Author":"Steve Anderson, PhD, MPP","Source Date":"2020-10-22","Source Additional Information":"page 17; Document was Recovered with the Internet Archive: Wayback Machine","Source URL":"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download"}
{"Possible Vaccine Adverse Events":"Meningitis","Source Title":"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation","Source Author":"Steve Anderson, PhD, MPP","Source Date":"2020-10-22","Source Additional Information":"page 17; Document was Recovered with the Internet Archive: Wayback Machine","Source URL":"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download"}
{"Possible Vaccine Adverse Events":"Meningoencephalitis","Source Title":"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation","Source Author":"Steve Anderson, PhD, MPP","Source Date":"2020-10-22","Source Additional Information":"page 17; Document was Recovered with the Internet Archive: Wayback Machine","Source URL":"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download"}
{"Possible Vaccine Adverse Events":"Multisystem Inflammatory Syndrome in Children","Source Title":"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation","Source Author":"Steve Anderson, PhD, MPP","Source Date":"2020-10-22","Source Additional Information":"page 17; Document was Recovered with the Internet Archive: Wayback Machine","Source URL":"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download"}
{"Possible Vaccine Adverse Events":"Myelitis","Source Title":"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation","Source Author":"Steve Anderson, PhD, MPP","Source Date":"2020-10-22","Source Additional Information":"page 17; Document was Recovered with the Internet Archive: Wayback Machine","Source URL":"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download"}
{"Possible Vaccine Adverse Events":"Myocarditis/pericarditis","Source Title":"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation","Source Author":"Steve Anderson, PhD, MPP","Source Date":"2020-10-22","Source Additional Information":"page 17; Document was Recovered with the Internet Archive: Wayback Machine","Source URL":"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download"}
{"Possible Vaccine Adverse Events":"Narcolepsy and cataplexy","Source Title":"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation","Source Author":"Steve Anderson, PhD, MPP","Source Date":"2020-10-22","Source Additional Information":"page 17; Document was Recovered with the Internet Archive: Wayback Machine","Source URL":"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download"}
{"Possible Vaccine Adverse Events":"Non-anaphylactic allergic reactions","Source Title":"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation","Source Author":"Steve Anderson, PhD, MPP","Source Date":"2020-10-22","Source Additional Information":"page 17; Document was Recovered with the Internet Archive: Wayback Machine","Source URL":"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download"}
{"Possible Vaccine Adverse Events":"Other acute demyelinating diseases","Source Title":"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation","Source Author":"Steve Anderson, PhD, MPP","Source Date":"2020-10-22","Source Additional Information":"page 17; Document was Recovered with the Internet Archive: Wayback Machine","Source URL":"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download"}
{"Possible Vaccine Adverse Events":"Pregnancy and birth outcomes","Source Title":"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation","Source Author":"Steve Anderson, PhD, MPP","Source Date":"2020-10-22","Source Additional Information":"page 17; Document was Recovered with the Internet Archive: Wayback Machine","Source URL":"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download"}
{"Possible Vaccine Adverse Events":"Stroke","Source Title":"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation","Source Author":"Steve Anderson, PhD, MPP","Source Date":"2020-10-22","Source Additional Information":"page 17; Document was Recovered with the Internet Archive: Wayback Machine","Source URL":"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download"}
{"Possible Vaccine Adverse Events":"Thrombocytopenia","Source Title":"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation","Source Author":"Steve Anderson, PhD, MPP","Source Date":"2020-10-22","Source Additional Information":"page 17; Document was Recovered with the Internet Archive: Wayback Machine","Source URL":"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download"}
{"Possible Vaccine Adverse Events":"Transverse myelitis","Source Title":"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation","Source Author":"Steve Anderson, PhD, MPP","Source Date":"2020-10-22","Source Additional Information":"page 17; Document was Recovered with the Internet Archive: Wayback Machine","Source URL":"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download"}
{"Possible Vaccine Adverse Events":"Vaccine enhanced disease","Source Title":"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation","Source Author":"Steve Anderson, PhD, MPP","Source Date":"2020-10-22","Source Additional Information":"page 17; Document was Recovered with the Internet Archive: Wayback Machine","Source URL":"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download"}
{"Possible Vaccine Adverse Events":"Venous thromboembolism","Source Title":"US Food and Drug Administration (FDA): Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation","Source Author":"Steve Anderson, PhD, MPP","Source Date":"2020-10-22","Source Additional Information":"page 17; Document was Recovered with the Internet Archive: Wayback Machine","Source URL":"https://web.archive.org/web/20201126033341/https://www.fda.gov/media/143557/download"}
{"Possible Vaccine Adverse Events":"(Serum) Shock","Source Title":"Serum Shock and Serum Reaction","Source Author":"K. G. Iyengar","Source Additional Information":"'The Indian Medical Gazette', May, 1943, pages 249-250","Source URL":"https://web.archive.org/web/20200207182423/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC5158424&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Anaphylactic symptoms","Source Title":"Serum Shock and Serum Reaction","Source Author":"K. G. Iyengar","Source Additional Information":"'The Indian Medical Gazette', May, 1943, pages 249-250","Source URL":"https://web.archive.org/web/20200207182423/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC5158424&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Cyanosis","Source Title":"Serum Shock and Serum Reaction","Source Author":"K. G. Iyengar","Source Additional Information":"'The Indian Medical Gazette', May, 1943, pages 249-250","Source URL":"https://web.archive.org/web/20200207182423/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC5158424&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Death","Source Title":"Serum Shock and Serum Reaction","Source Author":"K. G. Iyengar","Source Additional Information":"'The Indian Medical Gazette', May, 1943, pages 249-250","Source URL":"https://web.archive.org/web/20200207182423/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC5158424&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Death (if the Anaphylactic symptoms are not properly and effectively treated)","Source Title":"Serum Shock and Serum Reaction","Source Author":"K. G. Iyengar","Source Additional Information":"'The Indian Medical Gazette', May, 1943, pages 249-250","Source URL":"https://web.archive.org/web/20200207182423/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC5158424&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Respiration difficulties","Source Title":"Serum Shock and Serum Reaction","Source Author":"K. G. Iyengar","Source Additional Information":"'The Indian Medical Gazette', May, 1943, pages 249-250","Source URL":"https://web.archive.org/web/20200207182423/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC5158424&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Shock","Source Title":"Serum Shock and Serum Reaction","Source Author":"K. G. Iyengar","Source Additional Information":"'The Indian Medical Gazette', May, 1943, pages 249-250","Source URL":"https://web.archive.org/web/20200207182423/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC5158424&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Urticaria","Source Title":"Serum Shock and Serum Reaction","Source Author":"K. G. Iyengar","Source Additional Information":"'The Indian Medical Gazette', May, 1943, pages 249-250","Source URL":"https://web.archive.org/web/20200207182423/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC5158424&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Arthralgia","Source Title":"Serum Sickness-like Reactions","Source Author":"Joseph Yerushalmi, MD; Alex Zvulunov, MD; and Sima Halevy, MD","Source Additional Information":"'Cutis', Volume 69, May 2002, pages 395-397","Source URL":"https://web.archive.org/web/20200321001112/http://www.gums.ac.ir/Upload/Modules/Contents/asset68/069050395.pdf"}
{"Possible Vaccine Adverse Events":"Arthralgia/Arthritis","Source Title":"Serum Sickness-like Reactions","Source Author":"Joseph Yerushalmi, MD; Alex Zvulunov, MD; and Sima Halevy, MD","Source Additional Information":"'Cutis', Volume 69, May 2002, pages 395-397","Source URL":"https://web.archive.org/web/20200321001112/http://www.gums.ac.ir/Upload/Modules/Contents/asset68/069050395.pdf"}
{"Possible Vaccine Adverse Events":"Arthritis","Source Title":"Serum Sickness-like Reactions","Source Author":"Joseph Yerushalmi, MD; Alex Zvulunov, MD; and Sima Halevy, MD","Source Additional Information":"'Cutis', Volume 69, May 2002, pages 395-397","Source URL":"https://web.archive.org/web/20200321001112/http://www.gums.ac.ir/Upload/Modules/Contents/asset68/069050395.pdf"}
{"Possible Vaccine Adverse Events":"Cutaneous eruption","Source Title":"Serum Sickness-like Reactions","Source Author":"Joseph Yerushalmi, MD; Alex Zvulunov, MD; and Sima Halevy, MD","Source Additional Information":"'Cutis', Volume 69, May 2002, pages 395-397","Source URL":"https://web.archive.org/web/20200321001112/http://www.gums.ac.ir/Upload/Modules/Contents/asset68/069050395.pdf"}
{"Possible Vaccine Adverse Events":"Fever","Source Title":"Serum Sickness-like Reactions","Source Author":"Joseph Yerushalmi, MD; Alex Zvulunov, MD; and Sima Halevy, MD","Source Additional Information":"'Cutis', Volume 69, May 2002, pages 395-397","Source URL":"https://web.archive.org/web/20200321001112/http://www.gums.ac.ir/Upload/Modules/Contents/asset68/069050395.pdf"}
{"Possible Vaccine Adverse Events":"Gastrointestinal disturbances","Source Title":"Serum Sickness-like Reactions","Source Author":"Joseph Yerushalmi, MD; Alex Zvulunov, MD; and Sima Halevy, MD","Source Additional Information":"'Cutis', Volume 69, May 2002, pages 395-397","Source URL":"https://web.archive.org/web/20200321001112/http://www.gums.ac.ir/Upload/Modules/Contents/asset68/069050395.pdf"}
{"Possible Vaccine Adverse Events":"Lymphadenopathy","Source Title":"Serum Sickness-like Reactions","Source Author":"Joseph Yerushalmi, MD; Alex Zvulunov, MD; and Sima Halevy, MD","Source Additional Information":"'Cutis', Volume 69, May 2002, pages 395-397","Source URL":"https://web.archive.org/web/20200321001112/http://www.gums.ac.ir/Upload/Modules/Contents/asset68/069050395.pdf"}
{"Possible Vaccine Adverse Events":"Proteinuria","Source Title":"Serum Sickness-like Reactions","Source Author":"Joseph Yerushalmi, MD; Alex Zvulunov, MD; and Sima Halevy, MD","Source Additional Information":"'Cutis', Volume 69, May 2002, pages 395-397","Source URL":"https://web.archive.org/web/20200321001112/http://www.gums.ac.ir/Upload/Modules/Contents/asset68/069050395.pdf"}
{"Possible Vaccine Adverse Events":"Acute circulatory collapse","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Affection of the brachial plexus or part of the brachial plexus","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Albumin or possibly blood in the urine","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Anaphylactic reaction","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Anaphylactic reaction (The earliest symptoms of severe and dangerous anaphylactic reactions may be sweating, a feeling of heat throughout the body, a generalized pruritus, or an urticarial rash rapidly becoming generalized; an irritating cough, dyspnoea and wheeziness, a choking sensation, substernal oppression, or a feeling of constriction in the chest; retching or vomiting with cramp-like pains in the abdomen, sometimes diarrhoea, occasionally severe abdominal distension; and/or headache, giddiness, or sudden unconsciousness, in some cases followed by convulsions; while acute circulatory collapse and death may occur rapidly. The pulse is at first of good volume, slow and bounding, but in the dangerously ill patient it becomes rapid, weak, and thready, and there is a marked fall in blood pressure.)","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Angioneurotic oedema","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Arthritis","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Choking sensation","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Convulsions","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Cramp-like abdominal pains, with or without diarrhoea or vomiting or both","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Death","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Diarrhoea","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Difficulty in swallowing","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Dyspnoea","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Feeling of a heavy lump behind the sternum","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Feeling of constriction in the chest","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Fever","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Flaccid paralysis with the usual tenderness and hyper-aesthesia","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Generalized pruritus","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Giddiness","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Glandular enlargement","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Headache","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Heated body","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Irritating cough","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Local redness at the site of injection","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Morbilliform type of rash","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Neuritic pains in the shoulder regions","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Neurological complications","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Pain and swelling of the feet and ankles","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Pulse becomes rapid, weak, and thready, and there is a marked fall in blood pressure","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Retching","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Scapulo-humeral paralysis","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Scarlatiniform type of rash","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Serum sickness","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Serum sickness (They consist of fever, skin eruptions {Angioneurotic oedema [albumin or possibly blood in the urine], Morbilliform type of rash, Scarlatiniform type of rash, Urticarial weals}, glandular enlargement, and arthritis, often in this order. In the more severe reactions there may be difficulty in swallowing and a feeling of a heavy lump behind the sternum, while cramp-like abdominal pains, with or without diarrhoea or vomiting or both, are also not uncommon and may last for several days. Stiffness of the joints, especially after use, and an urticarial type of skin reaction after pressure may persist for weeks and sometimes for many months. One of my own patients, six months after his penicillin reaction, still developed pain and swelling of the feet and ankles after a brisk walk, and was unable to use his hands for heavy manual work. Neurological complications are rare but of special interest. The commonest is an affection of the brachial plexus or part of the brachial plexus, resulting in a scapulo-humeral paralysis. The patient often complains of neuritic pains in the shoulder regions, and these are followed fairly rapidly by a flaccid paralysis with the usual tenderness and hyper-aesthesia. Recovery usually occurs within six months.)","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Severe abdominal distension","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Skin eruptions","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Skin redness","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Stiffness of the joints","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Substernal oppression","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Sudden unconsciousness","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Sweating","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Urticarial rash","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Urticarial weals","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Vomiting with cramp-like pains in the abdomen","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}
{"Possible Vaccine Adverse Events":"Wheeziness","Source Title":"Serum and Anaphylactic Reactions","Source Author":"D. A. Williams, M.D., M.Sc., F.R.C.P.","Source Date":"1955-06-18","Source Additional Information":"'British Medical Journal: Emergencies in General Practice', 1952, 1, 4928, 1469-1471","Source URL":"https://www.bmj.com/content/1/4928/1469 and https://web.archive.org/web/20200209180050/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2062273&blobtype=pdf"}